Metformin: Restraining Nucleocytoplasmic Shuttling to Fight Cancer and Aging.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27984715.
- Also identified by DOI 10.1016/j.cell.2016.11.058.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this issue of Cell, Wu et al. employed C. elegans and human cell experiments to identify a pathway through which metformin increases lifespan and inhibits growth. A key transcriptional target, ACAD10, is activated when metformin induces nuclear exclusion of the GTPase RagC, thereby inhibiting mTORC1 through an unexpected mechanism.
Medical subject headings
- Caenorhabditis elegans
- Metformin